Dose-enhanced combined priming regimens for refractory acute myeloid leukemia and middle-and-high-risk myelodysplastic syndrome: a single-center, retrospective cohort study

OBJECTIVE: To assess chemotherapeutic regimens for refractory acute myeloid leukemia (AML) and middle-and-high-risk myelodysplastic syndrome (MDS). METHODS: Between 2004 and 2014, 44 patients with refractory AML and 36 patients with MDS were treated with new priming regimens (CHAG, CHTG, CHMG, or CT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Ma, Xiaorong, Wang, Jin, Xu, Yan, Zhang, Wanggang, Liu, Jie, Cao, Xingmei, He, Aili, Wang, Fangxia, Gu, Liufang, Lei, Bo, Wang, Jianli
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4920259/
https://ncbi.nlm.nih.gov/pubmed/27382304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S96427
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados